Log In
Print this Print this

D-Ivacaftor (C-10355)

  Manage Alerts
Collapse Summary General Information
Company Concert Pharmaceuticals Inc.
DescriptionOral deuterium-modified ivacaftor, a potentiator of cystic fibrosis transmembrane conductance regulator (CFTR)
Molecular Target
Mechanism of ActionCFTR stabilizer
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today